The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes
Abstract
Background—: The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time dependent, and guidelines recommend an arrival to treatment initiation (door-to-needle) time of ≤60 minutes. Methods and Results—: Data from acute ischemic stroke patients treated with tPA within 3 hours of symptom onset in 1082 hospitals participating in the Get With the Guidelines–Stroke Program from April 1, 2003, to September 30, 2009 were studied to determine frequency, patient and hospital characteristics, and temporal trends in patients treated with door-to-needle times ≤60 minutes. Among 25 504 ischemic stroke patients treated with tPA, door-to-needle time was ≤60 minutes in only 6790 (26.6%). Patient factors most strongly associated with door-to-needle time ≤60 minutes were younger age, male gender, white race, or no prior stroke. Hospital factors associated with ≤60 minute door-to-needle time included greater annual volumes of tPA-treated stroke patients. The proportion of patients with door-to-needle times ≤60 minutes varied widely by hospital (0% to 79.2%) and increased from 19.5% in 2003 to 29.1% in 2009 ( P <0.0001). Despite similar stroke severity, in-hospital mortality was lower (adjusted odds ratio, 0.78; 95% confidence interval, 0.69 to 0.90; P <0.0003) and symptomatic intracranial hemorrhage was less frequent (4.7% versus 5.6%; P <0.0017) for patients with door-to-needle times ≤60 minutes compared with patients with door-to-needle times >60 minutes. Conclusions—: Fewer than one-third of patients treated with intravenous tPA had door-to-needle times ≤60 minutes, with only modest improvement over the past 6.5 years. These findings support the need for a targeted initiative to improve the timeliness of reperfusion in acute ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Lees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Saver, J. L. (2006) · Stroke · doi:10.1161/01.str.0000196957.55928.ab · Cited by 2,181
Self-citationThrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181486 · Cited by 904
Self-citationEarly stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Recommendations for the Establishment of Primary Stroke Centers
Alberts, M. J. (2000) · JAMA · doi:10.1001/jama.283.23.3102 · Cited by 725
Albers, G. W., Bates, V. E., Clark, W. M., Bell, R., Verro, P., & Hamilton, S. A. (2000) · JAMA · doi:10.1001/jama.283.9.1145 · Cited by 700
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationJauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Self-citationHeart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Self-citationHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Self-citationThe immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Saver, J. L., Fonarow, G. C., Smith, E. E., Reeves, M. J., Grau-Sepulveda, M. V., Pan, W., Olson, D. M., Hernandez, A. F., Peterson, E. D., & Schwamm, L. H. (2013) · JAMA · doi:10.1001/jama.2013.6959 · Cited by 870
Self-citationAcute Stroke Intervention: A Systematic Review
Prabhakaran, S., Ruff, I., & Bernstein, R. A. (2015) · JAMA · doi:10.1001/jama.2015.3058 · Cited by 671
Animal models of ischemic stroke and their application in clinical research
Kleinschnitz, C., Fluri, F., & Schuhmann, M. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s56071 · Cited by 650
Fonarow, G. C., Zhao, X., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Xian, Y., Hernandez, A. F., Peterson, E. D., & Schwamm, L. H. (2014) · JAMA · doi:10.1001/jama.2014.3203 · Cited by 568
Self-citationReducing in-hospital delay to 20 minutes in stroke thrombolysis
Meretoja, A., Strbian, D., Mustanoja, S., Tatlisumak, T., Lindsberg, P. J., & Kaste, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31825d6011 · Cited by 560
Walter, S., Kostopoulos, P., Haass, A., Keller, I., Lesmeister, M., Schlechtriemen, T., Roth, C., Papanagiotou, P., Grunwald, I., Schumacher, H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70057-1 · Cited by 488
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke
Gelderblom, M., Weymar, A., Bernreuther, C., Velden, J., Arunachalam, P., Steinbach, K., Orthey, E., Arumugam, T. V., Leypoldt, F., Simova, O., et al. (2012) · Blood · doi:10.1182/blood-2012-02-412726 · Cited by 457
Ebinger, M., Winter, B., Wendt, M., Weber, J. E., Waldschmidt, C., Rozanski, M., Kunz, A., Koch, P., Kellner, P. A., Gierhake, D., et al. (2014) · JAMA · doi:10.1001/jama.2014.2850 · Cited by 447
Khatri, P., Yeatts, S. D., Mazighi, M., Broderick, J. P., Liebeskind, D. S., Demchuk, A. M., Amarenco, P., Carrozzella, J., Spilker, J., Foster, L. D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70066-3 · Cited by 416
Fonarow, G. C., Smith, E. E., Saver, J. L., Reeves, M. J., Hernandez, A. F., Peterson, E. D., Sacco, R. L., & Schwamm, L. H. (2011) · Stroke · doi:10.1161/strokeaha.111.621342 · Cited by 401
Self-citationStroke research at a crossroad: asking the brain for directions
Iadecola, C., & Anrather, J. (2011) · Nature Neuroscience · doi:10.1038/nn.2953 · Cited by 394
Bao, Q., Hu, P., Xu, Y., Cheng, T., Wei, C., Pan, L., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b01994 · Cited by 392
Stroke Thrombolysis: Save a Minute, Save a Day
Meretoja, A., Keshtkaran, M., Saver, J. L., Tatlisumak, T., Parsons, M. W., Kaste, M., Davis, S. M., Donnan, G. A., & Churilov, L. (2014) · Stroke · doi:10.1161/strokeaha.113.002910 · Cited by 366
Self-citationVascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.
Liu, J., Wang, Y., Akamatsu, Y., Lee, C. C., Stetler, R. A., Lawton, M. T., & Yang, G.-Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.004 · Cited by 335
Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
Datta, A., Sarmah, D., Mounica, L., Kaur, H., Kesharwani, R., Verma, G., Veeresh, P., Kotian, V., Kalia, K., Borah, A., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00806-z · Cited by 323
Streamlining of prehospital stroke management: the golden hour
Fassbender, K., Balucani, C., Walter, S., Levine, S. R., Haass, A., & Grotta, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70100-5 · Cited by 317
Wechsler, L. R., Demaerschalk, B. M., Schwamm, L. H., Adeoye, O. M., Audebert, H. J., Fanale, C. V., Hess, D. C., Majersik, J. J., Nystrom, K. V., Reeves, M. J., et al. (2017) · Stroke · doi:10.1161/str.0000000000000114 · Cited by 259
Self-citationLin, C. B., Peterson, E. D., Smith, E. E., Saver, J. L., Liang, L., Xian, Y., Olson, D. M., Shah, B. R., Hernandez, A. F., Schwamm, L. H., et al. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965210 · Cited by 254
Self-citationNational Performance on the Medicare SEP-1 Sepsis Quality Measure
Barbash, I. J., Davis, B., & Kahn, J. M. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003613 · Cited by 86
Deng, Y.-H., He, H.-Y., Ren, L., & Guo, T. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.244793 · Cited by 69
Metadata
- Authors
- Fonarow, G. C., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Grau-Sepulveda, M. V., Olson, D. M., Hernandez, A. F., Peterson, E. D., & Schwamm, L. H.
- Venue
- Circulation
- Published
- 2011-02-22
- Volume
- 123
- Issue
- 7
- Pages
- 750-758
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2121158877
- Cited by
- 579
- References
- 22
- FWCI
- 36.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.